Renalive LP
Asset
High-energy, low-protein nutritional formula designed for non-dialysis chronic kidney disease
- Stage
- Human trials
- Modality
- Supplement
- Target
- Not known
- 3
- Indications
- 1
- Trial
- 1
- Developer
Indications
3Chronic kidney disease
Human trials, Recruiting, NCT06892249, clinicaltrials.gov, 7 Oct 2026
Low protein dietary intake
Human trials, Recruiting, NCT06892249, clinicaltrials.gov, 7 Oct 2026
Malnutrition
Human trials, Recruiting, NCT06892249, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
Every asset’s record: target, stage, trials and the evidence behind it.